Patent · US Active

Induction of hemogenic endothelium from pluripotent stem cells

US9382531B2 · kind B2 · utility

12Cited by
7References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 21, 2013
Grant dateJul 5, 2016
Priority date
Expiry dateMay 22, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16043
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Described herein are methods and related compositions for inducing differentiation of human pluripotent stem cells (hPSCs) into hemogenic endothelium with pan-myeloid potential or restricted potential, by forced expression in the hPSCs of a combination of transcription factors as described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.